92 / 164
92
ESTRO SCHOOL
TARGET GROUP
The course targets senior residents, junior radiologists
and radiation oncologists who are interested to learn
and improve their knowledge on an optimal approach
tomultidisciplinary treatment management, exploiting
the use of imaging.
COURSE AIM
This course, jointly organised by ESOR (European
School of Radiology) and ESTRO, aims at promoting
an integrated approach between specialists involved
in multidisciplinary tumour boards to tailor the best
treatment for each individual patient by exploiting the
use of imaging.
New advanced imaging technology not only provides
morphological information on tumour extension, but
also information on tumour function and biology. It not
only allows a good evaluation of tumour response during
and after treatment, but also an early detection of tumour
recurrence. Radiation oncologists need to update their
understanding of the possibility of modern imaging to
optimise the multidisciplinary based clinical choices,
to allow individualised radiation treatment prescrip-
tion according to the tumour extension, response and
movement. Radiologists involved inmultidisciplinary
management teams increasingly recognise the impact of
their diagnostic information and description on clinical
decision-making and treatment planning.
LEARNINGOUTCOMES
By the end of this course participants should be able to:
• Understand the role of imaging in tailoring an indi-
vidualised risk based multimodality treatment by a
multidisciplinary team
• Identify themain relevant imaging features to optimise
treatment modalities in:
- upper abdomen
- prostate cancer
- rectal cancer
• Exploit imaging in tailoring andmonitoring safe dose
delivery.
COURSE CONTENT
Imaging technology in radiology and radiotherapy:
basic concepts
• PET, MRI, radiation therapy technology.
Liver tumours
• Primary liver tumour and colorectal metastases im-
aging evidences: anatomical, functional, monitoring,
follow-up
• What are the treatment options (surgery, RFA, TACE
versus SIRT, stereotactic radiotherapy)?
• What are the relevant imaging features that we need
to know before, during and after the treatments?
Imaging of liver tumours with modern CT and MRI
• New MRI technology for imaging moving organs.
Pancreatic tumours
• Pancreas tumour imaging evidences: anatomical,
functional, monitoring, follow-up
• What are the treatment options?
• What is the relevant imaging features that we need
to know before, during and after the treatments:
state-of-the-art and future imaging
• How can we adapt the treatment at the beginning
and along the therapies by imaging?
• Workshops liver and pancreas cancer.
Prostate cancer
• Prostate tumour imaging evidences: anatomical,
functional, monitoring, follow-up
• What is the pathway of tumour spread and what are
the treatment options?
• How accurate can imaging identify local tumour and
nodal spread before, during and after the treatments?
• How can we adapt the treatment at the beginning
and along the therapies by imaging?
• Workshops on prostate cancer.
Rectal cancer, tumour extension at primary staging
and at response evaluation
• What are the pathways of tumour (nodal) spread and
treatment options?
• How accurate can imaging identify local tumour and
nodal spread before, during and after the treatments
(CT, MRI, Diffusion MRI, PET)?
ESTRO/ESOR Multidisciplinary Approach
of Cancer Imaging
2-3 November 2017
Rome, Italy